Seeking AlphaThu, 11 Jun 2026 18:42:09 GMTEnliven Therapeutics, Inc. (ELVN) Discusses Updated Phase 1 ENABLE Trial Data for ELVN-001 in Previously Treated Chronic Myeloid Leukemia TranscriptELVN+3.39%
The Motley FoolSat, 28 Mar 2026 16:26:54 GMTEnliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 MillionELVN+3.39%
